Latest News
IDEAYA Biosciences, Inc.
- IDEAYA Biosciences, Inc. Estimates – NASDAQ:IDYA
- IDEAYA reports IDE849 trial data in lung cancer, neuroendocrine tumors By Investing.com
- Citizens reiterates Ideaya Biosciences stock rating ahead of ESMO By Investing.com
- IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma
- Citizens reiterates Ideaya Biosciences stock rating ahead of ESMO By Investing.com
- William Blair initiates Ideaya Biosciences stock with outperform rating By Investing.com
- Form 144 IDEAYA Biosciences For: 11 October By Investing.com
- IDEAYA Biosciences (IDYA) Stock Looks Priced At A Premium Despite R And D Promotion
- IDEAYA Biosciences Promotes Dr. Michael White to President of Research and Development
- IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and Development
- IDEAYA Biosciences promotes Michael White to R&D president By Investing.com
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Headlines from the last 30 days, linking to the original publishers. See all market news →